Aminotransim belongs to monocyclic β-lactam antibiotics, which has the advantages of strong bactericidal effect, low toxicity, wider scope of adaptation and better antibacterial effect. It can be used to treat infectious diseases, such as urinary tract infections, upper respiratory tract infections caused by gram-negative bacteria such as Escherichia coli, Pseudomonas aeruginosa and Klebsiella pneumoniae, or postoperative wound infections, ulcers and other soft tissue skin infections, peritonitis and other abdominal infections, and endometritis and other reproductive system infections. However, such drugs are prescription drugs and need to be used according to medical advice. Aminotransim has less cross-allergy with penicillin and cephalosporin antibiotics, so it can be used for the treatment of patients who are allergic to penicillin and cephalosporin when necessary, and should be taken as prescribed by the doctor. However, it should be noted that amineptine should not be used in combination with cefoxitin to avoid antagonistic effects in the body. The dosage should be adjusted for patients with impaired renal function, and pregnant women can use it under the guidance of professional doctors when necessary, but it is prohibited during lactation. Due to the different physical conditions of each patient, some patients may experience gastrointestinal discomfort, skin itching and other symptoms after application, and individual patients may also experience rash, taste changes, jaundice and other adverse reactions. In addition, patients should quit smoking, limit alcohol and eat a light diet while taking the drug, and increase water intake to speed up the metabolism of the drug in the body.